California Gene and Stem Cell Agency Sets Major, New Priorities for $3.9 Billion in Research Funding
Maximum impact sought, astronomically costly therapies targeted, rare disease platform to be created
SAN DIEGO -- Directors of California’s stem cell and gene therapy program unanimously approved sweeping new priorities today for its last $3.9 billion in research funding with hopes that it will make a “real difference” in the lives of the state’s residents.
The new directions take on the affordability of multimillion-dollar cures and also target gaps i…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.